JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Daniel J. Goldstein
David A. Dean
Mehmet C. Oz
Daniel Burkhoff
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, D. J.
Right arrow Articles by Dickstein, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, D. J.
Right arrow Articles by Dickstein, M. L.

J Thorac Cardiovasc Surg 1997;114:461-466
© 1997 Mosby, Inc.


CARDIOPULMONARY BYPASS,
MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

INHALED NITRIC OXIDE IS NOT A NEGATIVE INOTROPIC AGENT IN A PORCINE MODEL OF PULMONARY HYPERTENSION

Daniel J. Goldstein , MDa, David A. Dean , MDa, Arthur Smerling , MDb, Mehmet C. Oz , MDa, Daniel Burkhoff , MDc, Marc L. Dickstein , MDb

Supported by the Start-Up Grant, Department of Surgery, College of Physicians and Surgeons, Columbia University.

Received for publication June 18, 1996; revisions requested Sept. 19, 1996; revisions received Feb. 13, 1997; accepted for publication Feb. 21, 1997. Address for reprints: Daniel J. Goldstein, MD, Department of Surgery, 622 West 168th St., PO Box 268, New York, NY 10032.

Abstract

Background: Reports of pulmonary edema complicating inhaled nitric oxide therapy in patients with chronic heart failure and pulmonary hypertension have raised the concern that inhaled nitric oxide may have negative inotropic effects. Methods and results: We investigated the effect of multiple doses of inhaled nitric oxide (20, 40 and 80 ppm) on left ventricular contractile state in 10 open-chest pigs. Pressure-volume loops were generated during transient preload reduction to determine the end-systolic pressure-volume relationship and the stroke work-end-diastolic volume relation. Inhaled nitric oxide had no effect on systemic vascular resistance, cardiac output, end-systolic pressure-volume relationship or stroke work-end-diastolic volume relation under normal conditions. After induction of pulmonary hypertension (intravenous thromboxane A2 analog), inhalation of nitric oxide (80 ppm) resulted in a reduction in pulmonary vascular resistance (mean ± standard error of the mean) from 10.4 ± 3 to 6.5 ± 2 Wood units (p < 0.001) and in pulmonary artery pressure from 44 ± 4 to 33 ± 4 mm Hg (p < 0.05). Left ventricular end-diastolic volume rose from 53 ± 9 ml to 57 ± 10 ml (p = 0.02). No statistically significant change in cardiac output or systemic vascular resistance was observed. Inhaled nitric oxide had no effect on end-systolic pressure-volume relationship or stroke work-end-diastolic volume relation. Conclusions: In a porcine model of pulmonary hypertension, inhaled nitric oxide does not impair left ventricular contractile function. Therefore the cause of pulmonary edema observed in some patients receiving inhaled nitric oxide is not due to a negative inotropic action of this therapy.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Natori, N. Hasebe, Y.-T. Jin, T. Matsusaka, A. Ido, H. Matsuhashi, T. Ihara, and K. Kikuchi
Inhaled Nitric Oxide Modifies Left Ventricular Diastolic Stress in the Presence of Vasoactive Agents in Heart Failure
Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 895 - 901.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Argenziano and M. L. Dickstein
Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy
Ann. Thorac. Surg., May 1, 2000; 69(5): 1644 - 1645.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Krieg, T. Wahlers, W. Giess, R. Rohde, M. Hartrumpf, M. Bund, and A. Haverich
Inhaled nitric oxide and inhaled prostaglandin E1: effect on left ventricular contractility when used for treatment of experimental pulmonary hypertension
Eur. J. Cardiothorac. Surg., November 1, 1999; 14(5): 494 - 502.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. S Hayward, R. P Kelly, and P. S Macdonald
Inhaled nitric oxide in cardiology practice
Cardiovasc Res, August 15, 1999; 43(3): 628 - 638.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Lambermont, P. Kolh, O. Detry, P. Gerard, R. Marcelle, and V. D'Orio
Analysis of endotoxin effects on the intact pulmonary circulation
Cardiovasc Res, January 1, 1999; 41(1): 275 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Argenziano, D. A. Dean, N. Moazami, D. J. Goldstein, E. A. Rose, H. M. Spotnitz, D. Burkhoff, M. C. Oz, and M. L. Dickstein
Inhaled Nitric Oxide Is Not A Myocardial Depressant In A Porcine Model Of Heart Failure
J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 700 - 704.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The American Association for Thoracic Surgery.